Joanna Xing

Local delivery of angiogenesis-inhibitor minocycline combined with radiotherapy and oral temozolomide chemotherapy in 9L glioma.

H. Bow, X. Ye, H. Brem, 2014, Journal of neurosurgery.

BRAF mutation‐selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic‐potentiated synergism with the mTOR inhibitor temsirolimus

B. Trink, M. Xing, Dingxie Liu, 2010, International journal of cancer.

The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204).

B. Trink, M. Xing, Ruixin Liu, 2011, Biochemical and biophysical research communications.